Entry Point Capital, LLC Humacyte, Inc. Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 77,996 shares of HUMA stock, worth $404,019. This represents 0.25% of its overall portfolio holdings.
Number of Shares
77,996
Previous 5,180
1405.71%
Holding current value
$404,019
Previous $24.9 Million
98.29%
% of portfolio
0.25%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding HUMA
# of Institutions
150Shares Held
35.1MCall Options Held
279KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$26.2 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$24.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$10.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$6.57 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $534M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...